The eponymy game

I love a good bit of unintentional levity. One of my favorite discoveries is when an interviewee -- one of our own or even in another publication -- has a name that fits their field just a little too well. Now, call me a suspicious Aloysius, but when it happens twice in a week, in the same publication, I start getting wary. Today Jane Brody for the __New York Times__ writes on the linkurl:important exercises;http://www.nytimes.com/2006/12/19/health/19brody.html for maintaining health in aging

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
I love a good bit of unintentional levity. One of my favorite discoveries is when an interviewee -- one of our own or even in another publication -- has a name that fits their field just a little too well. Now, call me a suspicious Aloysius, but when it happens twice in a week, in the same publication, I start getting wary. Today Jane Brody for the __New York Times__ writes on the linkurl:important exercises;http://www.nytimes.com/2006/12/19/health/19brody.html for maintaining health in aging baby boomers. A key source warns that unless one does "something to slow the deterioration in muscle, bone strength and agility that naturally accompanies aging," he or she will become a prime candidate for, "boomeritis." The source: Nicholas A. DiNubile, an orthopedic surgeon at the Hospital of the University of Pennsylvania. Last week, a major news splash on the linkurl:effectiveness of circumcision;http://www.nytimes.com/2006/12/14/health/14hiv.html in reducing the risk of HIV transmission hit most major newspapers. __The New York Times?__ Donald G. McNeil judiciously has a key source tell us that circumcision is "not a magic bullet, but a potentially important intervention." The source: Kevin M. De Cock, director of H.I.V./AIDS for the World Health Organization. A quick search reveals that both individuals are regular sources. No conspiracy here, I guess.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies